Genetic interferonopathies: An overview
- PMID: 29773266
- DOI: 10.1016/j.berh.2017.12.002
Genetic interferonopathies: An overview
Abstract
Interferonopathies comprise an expanding group of monogenic diseases characterised by disturbance of the homeostatic control of interferon (IFN)-mediated immune responses. Although differing in the degree of phenotypic expression and severity, the clinical presentation of these diseases shows a considerable degree of overlap, reflecting their common pathogenetic mechanisms. Increased understanding of the molecular basis of these Mendelian disorders has led to the identification of targeted therapies for these diseases, which could also be of potential relevance for non-genetic IFN-mediated diseases such as systemic lupus erythematosus and juvenile dermatomyositis. In this paper, we summarise the current knowledge of the molecular basis, clinical features and the treatment available for monogenic interferonopathies.
Keywords: Aicardi-Goutières syndrome; CANDLE; Interferonopathies; Proteasome; SAVI.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
[Type I interferonopathies].Ann Dermatol Venereol. 2015 Nov;142(11):653-63. doi: 10.1016/j.annder.2015.06.018. Epub 2015 Sep 9. Ann Dermatol Venereol. 2015. PMID: 26363997 French.
-
Type I interferonopathies in pediatric rheumatology.Pediatr Rheumatol Online J. 2016 Jun 4;14(1):35. doi: 10.1186/s12969-016-0094-4. Pediatr Rheumatol Online J. 2016. PMID: 27260006 Free PMC article. Review.
-
Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.J Mol Med (Berl). 2016 Oct;94(10):1111-1127. doi: 10.1007/s00109-016-1465-5. Epub 2016 Sep 27. J Mol Med (Berl). 2016. PMID: 27678529 Free PMC article. Review.
-
Type I interferonopathies: a novel set of inborn errors of immunity.Ann N Y Acad Sci. 2011 Nov;1238:91-8. doi: 10.1111/j.1749-6632.2011.06220.x. Ann N Y Acad Sci. 2011. PMID: 22129056
-
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.Arthritis Res Ther. 2020 Apr 6;22(1):69. doi: 10.1186/s13075-020-02160-9. Arthritis Res Ther. 2020. PMID: 32252809 Free PMC article.
Cited by
-
Lung involvement in monogenic interferonopathies.Eur Respir Rev. 2020 Dec 15;29(158):200001. doi: 10.1183/16000617.0001-2020. Print 2020 Dec 31. Eur Respir Rev. 2020. PMID: 33328278 Free PMC article.
-
Genetic Testing Contributes to Diagnosis in Cerebral Palsy: Aicardi-Goutières Syndrome as an Example.Front Neurol. 2021 Apr 22;12:617813. doi: 10.3389/fneur.2021.617813. eCollection 2021. Front Neurol. 2021. PMID: 33967934 Free PMC article.
-
Kinase inhibition in autoimmunity and inflammation.Nat Rev Drug Discov. 2021 Jan;20(1):39-63. doi: 10.1038/s41573-020-0082-8. Epub 2020 Oct 19. Nat Rev Drug Discov. 2021. PMID: 33077936 Free PMC article. Review.
-
Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?Br J Dermatol. 2021 Dec;185(6):1090-1091. doi: 10.1111/bjd.20784. Epub 2021 Nov 8. Br J Dermatol. 2021. PMID: 34748213 Free PMC article.
-
Type I Interferonopathies in Childhood.Balkan Med J. 2023 May 8;40(3):165-174. doi: 10.4274/balkanmedj.galenos.2023.2023-4-78. Balkan Med J. 2023. PMID: 37161741 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials